LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | -33.3% | 19 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -40.0% | 19 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $5,000 | 0.0% | 19 | -13.6% | 0.00% | 0.0% |
| Q2 2018 | $5,000 | +66.7% | 22 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $3,000 | -62.5% | 22 | -62.7% | 0.00% | -66.7% |
| Q4 2017 | $8,000 | 0.0% | 59 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $8,000 | +14.3% | 59 | -3.3% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | +16.7% | 61 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $6,000 | 0.0% | 61 | -1.6% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |